Berberina: differenze tra le versioni
Contenuto cancellato Contenuto aggiunto
→Clinica: ref. |
→Clinica: ref. |
||
Riga 55:
*cardiologiche,<ref>{{cite journal | author = Qi MY, Feng Y, Dai DZ, Li N, Cheng YS, Dai Y | title = CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity | journal = Acta Pharmacol Sin | volume = 31 | issue = 2 | pages = 165–74 | date = February 2010 |id = PMID 20139899 | pmc = 4002834 | doi = 10.1038/aps.2009.180 | url = http://www.nature.com/aps/journal/v31/n2/abs/aps2009180a.html }}</ref><ref>{{cite journal | author = Huang WM, Yan H, Jin JM, Yu C, Zhang H | title = Beneficial effects of berberine on hemodynamics during acute ischemic left ventricular failure in dogs | journal = Chinese Medical Journal | volume = 105 | issue = 12 | pages = 1014–9 | date = December 1992 | id = PMID 1299549 }}</ref><ref>{{cite journal | author = Riccioppo Neto F | title = Electropharmacological effects of berberine on canine cardiac Purkinje fibres and ventricular muscle and atrial muscle of the rabbit | journal = British Journal of Pharmacology | volume = 108 | issue = 2 | pages = 534–7 | date = February 1993 | id = PMID 8448600 | pmc = 1908004 | doi = 10.1111/j.1476-5381.1993.tb12836.x }}</ref><ref>{{cite journal | author = Marin-Neto JA, Maciel BC, Secches AL, Gallo Júnior L | title = Cardiovascular effects of berberine in patients with severe congestive heart failure | journal = Clinical Cardiology | volume = 11 | issue = 4 | pages = 253–60 | date = April 1988 | id = PMID 3365876 | doi = 10.1002/clc.4960110411 }}</ref><ref>{{cite journal | author = Zeng XH, Zeng XJ, Li YY | title = Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy | journal = The American Journal of Cardiology | volume = 92 | issue = 2 | pages = 173–6 | date = July 2003 | id = PMID 12860219 | doi = 10.1016/S0002-9149(03)00533-2 }}</ref><ref>Wu M., Wang J., Liu L.-T. "Advance of studies on anti-atherosclerosis mechanism of berberine", Chinese Journal of Integrative Medicine 2010 16:2 (188-192)</ref><ref>{{cite journal | author = Kim JB, Yu JH, Ko E, Lee KW, Song AK, Park SY, Shin I, Han W, Noh DY | title = The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest | journal = Phytomedicine | volume = 17 | issue = 6 | pages = 436–40 | date = October 2009 | id = PMID 19800775 | doi = 10.1016/j.phymed.2009.08.012 }}</ref>
*metaboliche.<ref>{{cite journal | vauthors = Zhou JY, Zhou SW, Zhang KB, Tang JL, Guang LX, Ying Y, Xu Y, Zhang L, Li DD | title = Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats | journal = Biological & Pharmaceutical Bulletin | volume = 31 | issue = 6 | pages = 1169–76 | date = June 2008 | pmid = 18520050 | doi = 10.1248/bpb.31.1169 }}</ref><ref>{{cite journal | vauthors = Holy EW, Akhmedov A, Lüscher TF, Tanner FC | title = Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells | journal = Journal of Molecular and Cellular Cardiology | volume = 46 | issue = 2 | pages = 234–40 | date = February 2009 | pmid = 19014947 | doi = 10.1016/j.yjmcc.2008.10.011 }}</ref><ref>{{cite journal | vauthors = Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, Wang S, Wu J, Wang Y, Li Z, Liu J, Jiang JD | title = Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins | journal = Nature Medicine | volume = 10 | issue = 12 | pages = 1344–51 | date = December 2004 | pmid = 15531889 | doi = 10.1038/nm1135 | last13 = Wang | first12 = J | first13 = Y | last12 = Wu | first16 = JD | first14 = Z | first15 = J }}</ref><ref>{{cite journal | vauthors = Kim WS, Lee YS, Cha SH, Jeong HW, Choe SS, Lee MR, Oh GT, Park HS, Lee KU, Lane MD, Kim JB | title = Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity | journal = American Journal of Physiology– Endocrinology and Metabolism | volume = 296 | issue = 4 | pages = E812–9 | date = April 2009 | pmid = 19176354 | doi = 10.1152/ajpendo.90710.2008 }}</ref><ref>{{cite journal | vauthors = Li H, Dong B, Park SW, Lee HS, Chen W, Liu J | title = HNF1α plays a critical role in PCSK9 gene transcription and regulation by a natural hypocholesterolemic compound berberine | journal = The Journal of Biological Chemistry | volume = 284 | issue = 42 | pages = 28885–95 | date = August 2009 | pmid = 19687008 | pmc = 2781434 | doi = 10.1074/jbc.M109.052407 }}</ref><ref>{{cite journal | vauthors = Abidi P, Zhou Y, Jiang JD, Liu J | title = Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine | journal = Arteriosclerosis, Thrombosis, and Vascular Biology | volume = 25 | issue = 10 | pages = 2170–6 | date = October 2005 | pmid = 16100034 | doi = 10.1161/01.ATV.0000181761.16341.2b }}</ref><ref>{{cite journal | vauthors = Wang Y, Jia X, Ghanam K, Beaurepaire C, Zidichouski J, Miller L | title = Berberine and plant stanols synergistically inhibit cholesterol absorption in hamsters | journal = Atherosclerosis | volume = 209 | issue = 1 | pages = 111–7 | year = 2009 | pmid = 19782362 | doi = 10.1016/j.atherosclerosis.2009.08.050 }}</ref>
== Note ==
| |||